Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
23, Novo Nordisk released late-stage study results showing participants who took its next-generation obesity drug, CagriSema, didn't lose as much weight as those who took rival Eli Lilly's Zepbound
Nausea rates during the escalation phase nearly doubled when participants jumped straight to higher doses without the 2 mg initiation period
This matters for people at higher doses who want to minimize injection volume, and it is particularly relevant for 10 mg vial dosage protocols
Regardless of the delivery system, inject straight into the skin at a 90-degree angle
This low dose helps individuals acclimate to the medication, reducing the risk of side effects such as nausea and gastrointestinal discomfort
Check the Pen Before Use Before every injection, confirm that the Retatrutide pen is within its expiry date and inspect the solution carefully
